Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
102M
-
Shares change
-
+4.35M
-
Total reported value, excl. options
-
$643M
-
Value change
-
+$26.7M
-
Put/Call ratio
-
1.36
-
Number of buys
-
131
-
Number of sells
-
-91
-
Price
-
$6.30
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q2 2025
332 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q2 2025.
NOVAVAX INC - Common Stock (NVAX) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102M shares
of 160M outstanding shares and own 63.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.4M shares), BlackRock, Inc. (12.7M shares), SHAH CAPITAL MANAGEMENT (11.5M shares), Sanofi (6.88M shares), STATE STREET CORP (6.82M shares), D. E. Shaw & Co., Inc. (3.94M shares), COATUE MANAGEMENT LLC (3.84M shares), GEODE CAPITAL MANAGEMENT, LLC (3.77M shares), BANK OF AMERICA CORP /DE/ (3.14M shares), and UBS Group AG (2.26M shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.